SummaryActigen™ is a second generation, unique bioactive fraction derived from the outer cell wall of a specific strain of yeast, Saccharomyces cerevisiae, where it acts in the gut to bind pathogenic bacteria, preventing disease and competition for nutrients. In the current trial, 260 sows were used and fed either an unsupplemented control diet or one containing Actigen™ at 0.08% of the formulation during gestation, farrowing and lactation, to assess its impact on sow and piglet performance. Results showed significant increases in feed intake for sows fed Actigen™ pre-farrowing, but this was reversed during lactation, leading to a 7 kg saving in feed intake per animal. At birth, piglets weighed 42 g more in litters from Actigen™-fed sows compared to the control group. Weaning weight of the total litter from Actigen™ sows was significantly higher (P< 0.05) by 3.3 kg, although individual piglet weights were the same. Sows showed no significant loss in body weight during the trial, indicating that the improved piglet production was related to improved nutrient availability and perhaps Ig status of piglets due to the addition of Actigen™ in the diet.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.